Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23236| Title: | Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic. | Austin Authors: | Segelov, Eva;Underhill, Craig;Prenen, Hans;Karapetis, Christos;Jackson, Christopher;Nott, Louise;Clay, Tim;Pavlakis, Nick;Sabesan, Sabe;Heywood, Ellen;Steer, Christopher;Lethborg, Carrie;Gan, Hui K ;Yip, Desmond;Karanth, Narayan;Karikios, Deme;MacIntyre, C Raina | Affiliation: | Biosecurity Program, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia Department of Medicine, University of Otago, Dunedin, New Zealand Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia Department of Medical Oncology, The Canberra Hospital and ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia Department of Medical Oncology, Nepean Hospital and Nepean Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia Department of Oncology, Monash University and Monash Health, Melbourne, Victoria, Australia Border Medical Oncology, Albury-Wodonga Regional Cancer Centre, and University of NSW Rural Clinical School, Albury Campus, Albury, New South Wales, Australia Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australia Cancer Services, Monash Health, Melbourne, Victoria, Australia Department of Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia Department of Oncology, St John of God Subiaco Hospital and School of Medicine and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia Department of Medical Oncology, Townsville Cancer Centre, Townsville Hospital and Health Services, Townsville, Queensland, Australia Inclusive Health Research, St Vincent's Health Australia, Melbourne, Victoria, Australia La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia Department of Oncology, University Hospital Antwerp, Edegem, Belgium.. |
Issue Date: | 20-Aug-2020 | Date: | 2020-05-13 | Publication information: | JCO oncology practice 2020; 16(8): 467-482 | Abstract: | Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/23236 | DOI: | 10.1200/OP.20.00229 | Journal: | JCO oncology practice | PubMed URL: | 32401686 | Type: | Journal Article | Subjects: | COVID-19 |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.